Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17369569 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Radiation: iobenguane I 131

Indicates status has not been verified in more than two years